A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.
Shi J, Jiao T, Guo Q, Weng W, Ma L, Zhang Q, Wang L, Zhang J, Chen C, Huang Y, Wang M, Pan R, Tang Y, Hu W, Meng T, Liu SH, Guo J, Kong Y, Meng X.
Shi J, et al. Among authors: zhang q, zhang j.
Cancer Res. 2023 Nov 15;83(22):3783-3795. doi: 10.1158/0008-5472.CAN-23-1356.
Cancer Res. 2023.
PMID: 37668527
Free PMC article.